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Abstract
Background: Salmonella enterica serovar Enteritidis (S. Enteritidis) has caused major epidemics of
gastrointestinal infection in many different countries. In this study we investigate genome
divergence and pathogenic potential in S. Enteritidis isolated before, during and after an epidemic
in Uruguay.
Results: 266 S. Enteritidis isolates were genotyped using RAPD-PCR and a selection were
subjected to PFGE analysis. From these, 29 isolates spanning different periods, genetic profiles and
sources of isolation were assayed for their ability to infect human epithelial cells and subjected to
comparative genomic hybridization using a Salmonella pan-array and the sequenced strain S.
Enteritidis PT4 P125109 as reference. Six other isolates from distant countries were included as
external comparators.
Two hundred and thirty three chromosomal genes as well as the virulence plasmid were found as
variable among S. Enteritidis isolates. Ten out of the 16 chromosomal regions that varied between
different isolates correspond to phage-like regions. The 2 oldest pre-epidemic isolates lack phage
SE20 and harbour other phage encoded genes that are absent in the sequenced strain. Besides
variation in prophage, we found variation in genes involved in metabolism and bacterial fitness. Five
epidemic strains lack the complete Salmonella virulence plasmid. Significantly, strains with
indistinguishable genetic patterns still showed major differences in their ability to infect epithelial
cells, indicating that the approach used was insufficient to detect the genetic basis of this differential
behaviour.
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Conclusion: The recent epidemic of S. Enteritidis infection in Uruguay has been driven by the
introduction of closely related strains of phage type 4 lineage. Our results confirm previous reports
demonstrating a high degree of genetic homogeneity among S. Enteritidis isolates. However, 10 of
the regions of variability described here are for the first time reported as being variable in S.
Enteritidis. In particular, the oldest pre-epidemic isolates carry phage-associated genetic regions
not previously reported in S. Enteritidis. Overall, our results support the view that phages play a
crucial role in the generation of genetic diversity in S. Enteritidis and that phage SE20 may be a key
marker for the emergence of particular isolates capable of causing epidemics.
Background
Infection with non-typhoidal Salmonella enterica is a
major cause of food-borne disease in humans worldwide
[1-3]. Animals and their products, particularly poultry
and chicken eggs, are regarded as the main sources of this
pathogen, although others, such as fresh vegetables, are
also important [4-6]. A peculiar epidemiological feature
of salmonellosis is that major outbreaks and epidemics
are commonly associated with a dominant serovar of S.
enterica and the particular serovar involved shows tempo-
ral and geographical variation.
Until the 1980s S. enterica serovar Typhimurium (S. Typh-
imurium) was the most common serovar isolated from
humans worldwide. However, in the late 1980s S. Enteri-
tidis emerged as the most common cause of human sal-
monellosis in Europe and during the 1990s it became the
most prevalent serovar in many countries worldwide [7-
9]. In Uruguay, until 1994 S. Typhimurium was the most
frequently isolated serovar and S. Enteritidis was only iso-
lated sporadically [10-12]. The first significant recorded
outbreak of S. Enteritidis infection occurred in 1995 and
from 1997 onwards it became the most prevalent serovar.
After 2004 the number of isolates started to decline mark-
edly, suggesting a post-epidemic period. The reasons for
this worldwide serovar shift are still not understood, and
several hypotheses have been proposed, including the
existence of a rodent reservoir for S. Enteritidis, or the epi-
demiological change induced by vaccination of poultry
against the closely related S. enterica serovar Gallinarum
[13].
S. Enteritidis is highly clonal [14,15] so it has been diffi-
cult to discriminate genetic types by methods like multilo-
cus sequence typing (MLST), pulsed field gel
electrophoresis (PFGE), random amplified polymor-
phism DNA-PCR (RAPD-PCR) or ribotyping. DNA micro-
array-based comparative genomic hybridization (CGH)
has been used to explore genetic diversity and to search for
genes involved in virulence, transmission and host specif-
icity in several different microbial pathogens [16-19] as
well as in different serovars of S. enterica [20-26].
In this study we have genotyped 266 isolates of S. Enteri-
tidis and defined a set of 29 isolates from before, during
and after the epidemic period in Uruguay, covering differ-
ent sources of isolation and representing the different pro-
files obtained by genotyping. To look for differences in
pathogenic potential, these 29 isolates were assayed for
their ability to invade Caco-2 epithelial cells. To correlate
Table 1: Uruguayan S. Enteritidis isolates included in this study. 
ISOLATION PERIOD
Sample origin Pre-epidemic epidemic Post-epidemic TOTAL
Faeces 1 112 22 135
Blood 1 34 6 41
Urine 0 2 1 3
Spinal fluid 0 3 1 4
Other 0 9 2 11
Subtotal human 2 160 32 194
Food* 4 39 8 51
Animal 0 12 1 13
Feed 0 7 1 8
Subtotal non-human 4 58 10 72
TOTAL 6 218 42 266
*Includes eggs and other products used for human consumption.
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any differences in pathogenic potential with genomic var-
iation we exploited a pan-Salmonella microarray for CGH.
Six other S. Enteritidis isolated from distant parts of the
world were included in the CGH analysis to compare the
diversity seen in Uruguay with that found elsewhere.
Results and Discussion
Genotyping assays
All 266 S. Enteritidis isolates (Table 1) were subjected to
RAPD-PCR analysis using 5 different primers and were
compared to S. Enteritidis phage type 4 (PT4) strain
P125109. The complete sequence of S. Enteritidis PT4
P125109 has been determined and it acts as the reference
for all the analyses reported here [27].
Of the S. Enteritidis isolates tested in this study 96%
showed the same amplification pattern as S. Enteritidis
PT4 P125109 with all primers using RAPD-PCR. Only 10
isolates (3.8%) showed differences in the amplification
pattern obtained with at least 1 primer.
Thirty-seven isolates from different origins, periods and
RAPD types, were subjected to PFGE after cleavage of their
DNA with XbaI. Of these, 26 generated a restriction pat-
tern identical to S. Enteritidis PT4 P125109, whereas 11
showed subtle differences (1 to 3 different bands, corre-
sponding to 96 to 91% identity with S. Enteritidis PT4
P125109). When both typing methods were considered
together, 21 out of the 37 isolates were indistinguishable
from S. Enteritidis PT4 P125109, while 5 differed by both
methods and 11 differed by a single typing method. The 5
isolates differing by both methods included the 2 oldest
pre-epidemic isolates (31/88 and 8/89), 2 isolated from
food (206/99 and 32/02) and 1 isolated from human
blood (214/02).
Overall these results revealed a high degree of genetic uni-
formity within S. Enteritidis circulating in Uruguay, with
the great majority of isolates belonging to the same
genetic profile as S. Enteritidis PT4 P125109.
Next, 29 isolates were selected with the aim of maximiz-
ing the chances of finding divergence among the isolates.
For this, we selected isolates that span the pre-epidemic,
epidemic and post-epidemic periods in Uruguay and that
cover any particular profile found in the RAPD and/or
PFGE assays, and all possible sources of isolation (Table
2). The selected isolates were subjected to further pheno-
typic and genotypic characterization.
Caco-2 invasion assays
In order to gain information about the pathogenic poten-
tial of S. Enteritidis, the 29 isolates plus the S. Enteritidis
PT4 P125109 used as reference, were assayed for their
ability to invade Caco-2 human epithelial cells (Table 2).
Contrary to the homogeneity observed when using the
typing techniques, marked differences were observed
between isolates in the cell invasion assays. Nine were
impaired in their ability to invade (≤ 30% of the invasive-
ness of S. Enteritidis PT4 P125109; p < 0,01). These
include the 2 oldest pre-epidemic isolates 31/88 and 8/89,
3 of 5 from human systemic disease, (132/99, 199/02 and
214/02), and 3 from food (48/01, 251/01 and 254/01).
One particular isolate (130/99) defective in invasiveness
was also impaired for growth in LB broth (data not
shown). Of note, 7 out of these 9 isolates were distinct
from S. Enteritidis PT4 P125109 when evaluated by RAPD
or PFGE assays (see Table 2). All other isolates tested were
similar to S. Enteritidis PT4 P125109 in this invasion
assay. Considering all human isolates, 13 out of 15
obtained from gastroenteritis but only 1 out of 5 from
invasive disease were as invasive as S. Enteritidis PT4
P125109 (p = 0,01 Fisher's exact test). Overall, these
results suggest that impaired invasiveness is less frequent
among isolates that cause human gastroenteritis, an
assumption that merit future studies with a larger panel of
in vitro and in vivo phenotypical assays.
Comparative genomics of S. Enteritidis
These results suggest the existence of genetic determinants
for the phenotypic differences that were not highlighted
by the genotyping methods used. Consequently, we con-
ducted a CGH study on the same 29 S. Enteritidis isolates
from Uruguay used for the Caco-2 invasion assays. We
also included in the CGH analysis 4 S. Enteritidis isolates
from Kenya, and 2 isolates from the UK as external com-
parators.
The analysis was conducted using a pan-Salmonella micro-
array based on the S. Typhi CT18 genome, complemented
with strain-specific genes from S. Enteritidis PT4
P125109, S. Typhimurium SL1344 and DT104, S. Galli-
narum, S. Typhi Ty2 and S. bongori (see methods). Genes
specific for some of these strains were not included in pre-
viously reported S. Enteritidis CGH analysis. Of 5863 fea-
tures on the microarray, 3978 correspond to genes present
in S. Enteritidis PT4 P125109 (3921 chromosomal and 57
plasmid genes) and 1885 to genes absent in S. Enteritidis
PT4 P125109 but present in other salmonellae.
Overall, the analysis produced results that extend those
previously reported by others using different sets of iso-
lates [21,24,25], and confirm that there is considerable
genetic homogeneity in S. Enteritidis, despite geographi-
cal, temporal and source differences between the different
isolates. However, we also found a number of genomic
regions and single genes that have not been described as
variable among S. Enteritidis field isolates.
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Table 2: Description and results obtained for the Uruguayan isolates used for CGH and Caco-2 invasion assays
ISOLATE 
DESIGNATIO
N
PHAGE 
TYPE
PERIOD OF 
ISOLATION
ORIGIN RAPD-PCRa PFGEb CGHc P CGHc A SVPd Caco-2 
invasivenesse
31/88 UNTY Pre epidemic Coproculture 1 92% 32 43[4] + -
08/89 4b Haemoculture 1 96% 33 41 + -
53/94 4b Food 0 100% 1 38 + +
57/94 4 Food 0 100% 1 0[14] + +
47/95* 4 Epidemic Coproculture 0 92% 2 0 + +
51/95 4 Coproculture 1 100% 0 0 + +
108/95* 4 Coproculture 0 100% 0 0 + +
49/98 4 Food 0 100% 3 6[15] + +
80/98 4b Bone punction 0 100% 0 1 + +
100/99* 4 Coproculture 0 96% 0 0 + +
130/99 4b Coproculture 0 96% 0 0 - -
132/99 4 Haemoculture 0 100% 0 0[33] + -
206/99 4b Food 1 91% 0 45 - +
32/00 4 Animal 0 100% 0 8[5] + +
125/00* 4 Coproculture 0 92% 0 0 + +
48/01 4 Food 2 100% 0 0 + -
251/01 RDNC Egg 0 100% 0 0 + -
254/01 4 Egg 0 96% 0 0 + -
8/02* 4 Coproculture 0 100% 0 0 + +
32/02 4 Egg 1 96% 0 1 - +
65/02 4 Coproculture 0 100% 0 0 + +
77/02* 4 Coproculture 0 100% 2 0 + +
199/02 4 Haemoculture 1 ND 0 0 - -
214/02 4 Haemoculture 1 96% 0 0 - -
47/03 4 Coproculture 1 ND 0 6 + +
106/04 4 Post epidemic Coproculture 1 100% 0 0 + +
10/05 RDNC Coproculture 0 100% 2 0 + +
BMC Microbiology 2009, 9:237 http://www.biomedcentral.com/1471-2180/9/237
Page 5 of 16
(page number not for citation purposes)
Of the 3921 chromosomal genes from S. Enteritidis PT4
P125109 represented on the microarray (covering about
90% of the genome), 3804 were shared by all S. Enteri-
tidis isolates tested here and are considered to be the core
genome of S. Enteritidis. Among these genes, only 7 were
specific to S. Enteritidis, i.e. absent in all other sequenced
Salmonella strains, and they are all included in the recently
annotated phage SE14 [27]. Interestingly, this region was
previously postulated as a region of difference between S.
Enteritidis and other serovars [28], although more
recently it was reported as absent in two S. Enteritidis iso-
lates corresponding to PT6b and PT35 (Region A04 in ref-
erence [21]).
Considering genes that were variably present between the
isolates tested, 117 genes known to be present on the
chromosome of S. Enteritidis PT4 P125109 were absent,
or divergent, in at least one of the S. Enteritidis isolates
tested (Regions 1 to 9 and single genes 1 to 9, see Table 3).
Conversely 116 genes were present in at least one isolate
but absent from S. Enteritidis PT4 P125109 (Regions 10
to 16 and individual genes 10 to 26, see Table 4). These
results are summarized in Figure 1. These 233 genes
together with other 201 genes previously described as var-
iable present in S. Enteritidis [21] can be considered so far
the S. Enteritidis dispensable genome (DG). Of note, 10
of the 16 regions of variability (Reg 1, 3, 5-8, 10, 12-14)
are reported for the first time as being variable among S.
Enteritidis strains. Variation in plasmid genes is not
included in this figure and has been treated separately (see
below).
Detailed analysis of the genes within the DG showed that
prophage-like elements constitute the major source of
genetic variation distinguishing these S. Enteritidis iso-
lates. However, this analysis also revealed some interest-
ing differences in metabolic potential and in genes
associated with restriction-modification systems (dis-
cussed below).
S. Enteritidis variable prophage-like regions within the DG
Of the annotated prophages from S. Enteritidis PT4
P125109 represented on the array one Kenyan and 4 Uru-
guayan isolates lacked ϕSE20 (Region 4 in our analysis), a
~41 kb phage similar to ϕST64B. Phage SE20 is thought to
be intact and a recent acquisition in S. Enteritidis PT4
P125109 and like ϕST64B, it carries fragments of the sopE
and orgA genes, which have been implicated in Salmonella
virulence [27,29]. Two of the 4 Uruguayan isolates that
lack ϕSE20 were isolated from human infections more
than 5 years before the beginning of the epidemic in Uru-
guay (31/88 and 8/89), whereas the other 2 were from
food samples, one from before (53/94) and the other
from the middle (206/99) of the epidemic. Similarly, Por-
wollik and collaborators have reported that this phage
(called ϕST64B in their work) is absent in strains of S.
Enteritidis isolated more than 50 years ago and suggested
that acquisition of this phage may be related to the emer-
gence of S. Enteritidis as being epidemic worldwide [21].
We corroborated the presence of ϕSE20 among the 29
Uruguayan isolates by PCR using two set of ϕSE20-specific
primers that amplify fragments of sb9 and sb41 (SEN1935
and SEN1993 respectively). Only isolates 31/88, 8/89,
53/94 and 206/99 were negative validating the microarray
results. We extended the PCR screening with sb41 primers
to another 85 S. Enteritidis isolates from the original sam-
ple set, which included 28 isolates from human gastroen-
teritis, 30 isolates from invasive human disease and 27
isolates from non-human origin (including the 2 other
pre-epidemic isolates that had not been included in the
CGH analysis). Among them we found only 4 other iso-
lates that lack sb41, i.e. 50/99 and 211/00 originating
from food, 107/99 from enteric disease and 209/01 from
invasive infection. In summary, we found that only 5 out
of 108 isolates tested from the epidemic and post-epi-
demic periods lack ϕSE20, whereas 3 out of 6 pre-epi-
demic isolates lack this phage. This provides further
support for the idea that the presence of ϕSE20 is a marker
for the emergence of particular isolates as epidemic strains
[21,27].
92/05 4 Coproculture 0 96% 0 1[32] + +
93/05 4 Coproculture 0 100% 0 0 + +
a- The number of primers which showed differences in RAPD -PCR profiles as compared to S. Enteritidis PT4 P125109 is indicated.
b- Expressed as percentage of identity as compared to S. Enteritidis PT4 P125109: 96% of identity corresponds to 1 band of difference, 92% to 2 
bands and 91% to 3 bands of difference.
c- P: number of chromosomal genes predicted as present in test isolate but absent in reference S. Enteritidis PT4 P125109. A: number of 
chromosomal genes predicted as absent in test isolate but present in S. Enteritidis PT4 P125109. Numbers between brackets indicate genes from 
the S. Enteritidis PT4 P125109 virulence plasmid lost or divergent in the tested isolate (total plasmid genes: 57).
d- Results from Kado and Liu analysis [53]. +: Salmonella virulence plasmid present, -: absent.
e- Results from Caco-2 invasion assays. -: invasiveness ≤ 30% of PT4, +: > 30% of PT4. All isolates marked with - showed significant differences 
compared to PT4 (p < 0,01). In Isolate Designation column, an * indicates strains previously reported [12].
Table 2: Description and results obtained for the Uruguayan isolates used for CGH and Caco-2 invasion assays (Continued)
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Table 3: Regions (REG) and single genes (SING) present in the S. Enteritidis PT4 P125109 chromosome and predicted by CGH analysis 
as absent or divergent in at least one S. Enteritidis isolate.
ISOLATE DESIGNATION GENE RANGE HOMOLOGOUSa FUNCTION/GENE 
PREDICTION
REG 1 AF3353 SEN0910-SEN0912 No Part of SE10 prophage remnant.
REG 2# AF3353 SEN1394-SEN1395 No Part of SE14 prophage.
REG 3 9296/98 SEN1524-SEN1530 CT18, TY2, LT2, DT104, SL1344, 
SBG, SPA, SGAL
Membrane, transport and 
hypothetical proteins
REG 4# 31/88, 8/89, 53/94, 206/99, AF3353 SEN1920-SEN1966 SDT104 Phage SE20
REG 5 AF3353 SEN1970-SEN1999 SGAL Genomic island ROD 21, coding to 
HNS
REG 6 31/88, 49/98, 92/05 (onlySEN2240) SEN2238-SEN2243 CT18, TY2, LT2, DT104, SL1344, 
SBG, SPA, SGAL
CytochromeC synthesis, ferredoxin
REG 7 32/00, 31/88, 49/98 SEN2441-SEN2446 CT18, TY2, LT2, DT104, SL1344, 
SPA, SGAL
Alcohol dehydrogenase, aldehyde 
dehydrogenase, ethanolamine 
utilization
REG 8 47/03 SEN2761-SEN2763 CT18, TY2, LT2, DT104, SL1344, 
SBG, SPA, SGAL
rpoS, unknown
REG 9# AF3176, 47/03 (only SEN4286) SEN4286-SEN4291 SGAL ROD40, Type I Restriction 
Modification System 
Methyltransferase
SING 1 32/00 SEN2051 CT18, TY2, LT2, DT104, SL1344, 
SPA, SGAL
pduS (ferredoxin)
SING 2 32/02 SEN2293 CT18, TY2, LT2, SL1344, SBG, SPA, 
SGAL
Hypothetical Protein
SING 3 32/00 SEN2494 CT18, LT2, SL1344, DT104, SGAL ratB, lipoprotein
SING 4 47/03 SEN2819A CT18, TY2, DT104, SL1344, SPA, 
SGAL
fucP, L-fucose permease
SING 5 47/03 SEN2841 CT18, TY2, LT2, DT104, SL1344, 
SBG, SPA, SGAL
ppdB, prepilin peptidase dependent 
protein B precursor
SING 6 80/98 SEN2912 CT18, TY2, LT2, DT104, SL1344, 
SBG, SPA, SGAL
pgk, phosphoglycerate kinase
SING 7 53/94 SEN3403 CT18, TY2, LT2, DT104, SL1344, 
SBG, SPA, SGAL
Lipoprotein
SING 8 32/00 SEN3627 CT18, TY2, LT2, DT104, SL1344, 
SBG, SPA, SGAL
yidR, putative ATP/GTP binding 
protein
SING 9 32/00 SEN3636 CT18, TY2, LT2, DT104, SL1344, 
SBG, SPA, SGAL
yhjA, probable cytochromeC 
peroxidase
a indicates when the REG or SING has homologous region described in other sequenced Salmonella serovars (see list of abbreviations). # indicates 
that the genetic region was previously described as variable among S. Enteritidis isolates [21].
BMC Microbiology 2009, 9:237 http://www.biomedcentral.com/1471-2180/9/237
Page 7 of 16
(page number not for citation purposes)
Table 4: Regions (REG) and single genes (SING) absent in the S. Enteritidis PT4 P125109 chromosome and predicted by CGH analysis 
as present in at least one Enteritidis isolate.
ISOLATE DESIGNATION GENE RANGE HOMOLOGOUSa GENE DESCRIPTION
REG 10A 31/88 SDT1842-SDT1843 No Similar to E coli K12 ymfD, ymfE phage 
proteins
REG 10B 31/88, 8/89, 47/95 
(only SDT1860)
SDT1846-SDT1860 No Shigella Phage proteins
REG 11# 8/89, AF3353, 31/88 
(only STY1036)
STY1034-STY1036 SL1344, LT2, TY2, DT104 Part of Gifsy-2 antitermination ninG, 
dnaJ
REG 12A 31/88, 8/89 SL2583-SL2584 SBG Phage related protein
REG 12B 31/88, 8/89 SL2588-SL2594 some SBG Phage proteins, putative 
methyltransferase, unknown
REG 12C 31/88, 8/89 SL2599-SL2600 LT2, SDT104 Gifsy-1 integrase, unknown
REG 13 AF3353, 8/89 (only STY1013) STY1011-STY1013 TY2, LT2, SL1344, DT104 Phage proteins 
(integrase, excisionase)
REG 14 AF3353, 8/89 (only STY1021) STY1021-STY1024 TY2, LT2, SL1344, DT104 Phage proteins
REG 15A# AF3353 STY3674-STY3689 SL1344, LT2, TY2, SPA ST35 phage proteins
REG 15B AF3353 STY3696-STY3702 TY2, SPA, LT2, SL1344 ST35 phage proteins
REG16A AF3353 STY4600-STY4602 TY2, SPA. LT2, SL1344, SBG 
(except 4600)
Part of S. Typhi phage SopE
REG16B AF3353 STY4605-STY4607 TY2, SPA, LT2, SL1344, SBG Part of S. Typhi phage SopE
REG16C# AF3353 STY4613-STY4628 TY2, SPA. LT2, SL1344 
(except 4619)
Part of S. Typhi phage SopE
REG16D# AF3353 STY4633-STY4635 SL1344, LT2, SPA Part of S. Typhi phage SopE
REG16E AF3353 STY4638-STY4639 TY2, SPA, LT2. SL1344 
(except 4639)
Part of S. Typhi phage SopE
REG16F AF3353 STY4641-STY4645 TY2, SPA. LT2 (except 4641) Part of S. Typhi phage SopE
SING 10 53/94, 57/94, 47/95, 49/98 SBG0310 No unknown
SING 11 31/88 SBG3602 LT2, CT18 Hypothetical protein
SING 12 S1400/94 STY0114 TY2, SPA Putative IS transposase
SING 13 77/02 STY0480 TY2, SPA Hypothetical protein
SING 14 49/98 STY4582 No Exported protein
SING 15 31/88 STM0293 SL1344, DT104 unknown
SING 16 31/88 SDT2674 SL1344 unknown
SING 17 31/88, 8/89 STM2584 DT104, SL1344 gogB, leucine-rich repeat protein
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SING 18 49/98 STY3619 TY2, SPA, LT2, SL1344 Conserved membrane protein
SING 19 AF3353 SBG0897 SBG Phage related protein
SING 20 AF3353 SDT1865 No unknown
SING 21 AF3353 SDT3861 No unknown
SING 22 AF3353 STY1073 LT2, TY2 unknown
SING 23 AF3353 STY2013 TY2 unknown
SING 24 AF3353 STY4600 TY2, SPA Transcriptional regulator
SING 25 AF3353 STY4619 TY2, SPA Putative membrane protein
SING 26 AF3353 STY4639 TY2, LT2, SPA Hypothetical protein
a indicates when the REG or SING has homologous region described in other sequenced Salmonella serovars (see list of abbreviations). # indicates 
that the genetic region was previously described as variable among S. Enteritidis isolates [21].
Table 4: Regions (REG) and single genes (SING) absent in the S. Enteritidis PT4 P125109 chromosome and predicted by CGH analysis 
as present in at least one Enteritidis isolate. (Continued)
Graphic representation of the chromosomal genes found in this study as part of S. Enteritidis Dispensable Genome (233 genes)Figure 1
Graphic representation of the chromosomal genes found in this study as part of S. Enteritidis Dispensable 
Genome (233 genes). In blue, genes present in the S. Enteritidis PT4 P125109 chromosome and predicted as absent in the 
test strain. In red, genes absent in the S. Enteritidis PT4 P125109 chromosome and predicted as present in the test strain. In 
white, genes present or absent in both reference and test strains. Only those isolates for which any divergence is predicted are 
shown. S. Enteritidis PT4 P125109 results are shown as reference.
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It has been proposed that S. Enteritidis might be divided
into two lineages based on the presence or absence of four
phages, i.e. ϕSE20, Fels2 and S. Typhi CT18 ST27 and
ST35 phages [21]. One lineage, the PT4 lineage, was
defined as positive for ϕSE20 and negative for Fels2, ST27
and ST35, whereas a second lineage, the PT8-PT13 line-
age, was defined as negative for ϕSE20 but positive for
Fels2, ST27 and ST35. Our results however, show that all
Uruguayan isolates tested belong to the PT4 lineage as
defined by Guard-Petter [30], and are negative for Fels2,
ST27 and ST35 phage regions regardless of the presence or
absence of ϕSE20, thus they do not strictly fall within the
two separates groups as previously proposed [21].
Several prophage-related genes present on the microarray
from other non-S. Enteritidis serovars were found in some
of the isolates. Many of them are grouped here as regions
10 to 16 (Table 4). Regions 15 and 16 were only found in
the Kenyan S. Enteritidis AF3353 isolate. Region 15
encodes 23 (out of 45) genes corresponding to sequences
of the S. Typhi CT18 P2-family prophage ST35 [31].
Region 16 harbours 32 genes from another P2-family
prophage, ϕSopE, also found in S. Typhimurium and S.
Typhi that encodes the type III secretion system effector
protein SopE important for invasion of enterocytes [31-
33]. In S. Enteritidis, SopE is encoded in an unrelated
lambdoid phage SE12 [27,33], which is present in all S.
Enteritidis isolates tested here.
We found that the two oldest Uruguayan pre-epidemic
isolates (31/88, 08/89) harbour 31 genes (regions 10 to
12) that correspond to phage genes carried by S. Typhimu-
rium DT104 or S. Typhimurium SL1344, or genes from
ϕGifsy-1 of S. Typhimurium LT2. Interestingly, Regions
10 and 12A-B were not previously found in S. Enteritidis,
although this may be due to the fact that previously
reported S. Enteritidis CGH analysis used microarrays that
lacked these regions.
Both pre-epidemic isolates also carry gogB. GogB is a
ϕGifsy-1-encoded type III secreted substrate of both SPI-1
and SPI-2 TTSS in S. Typhimurium LT2 [34]. It has been
reported that some salmonellae have Gifsy-1 but not gogB
whereas others do not have Gifsy-1 but do have gogB, sug-
gesting that this gene has been recently acquired by Gifsy-
1 [34,35]. To the best of our knowledge, this is the first
report of S. Enteritidis harbouring this gene. Thus, we
designed a pair of primers that amplifies a 248 bp frag-
ment of gogB, and used them to screen for its presence
among the 85 strains also assayed for ϕSE20. No other
isolate was positive for gogB. We then sequenced the PCR
fragment from both pre-epidemic strains and found that
the sequence has 99% of identity with S. Typhimurium
LT2 gogB.
In summary, 10 out of the 16 variable genomic regions
found among S. Enteritidis isolates correspond to phage-
like regions, suggesting that, as in other serovars of Salmo-
nella, phages play a crucial role in the generation of
genetic diversity in S. Enteritidis [20,31].
Variations in the content of genes involved in metabolism
Our CGH data highlighted other regions of variation.
Region 7, harbouring 6 out of 17 genes of the eut operon,
is absent in 1 pre-epidemic (31/88) and 2 non-human
epidemic (32/00 and 49/98) S. Enteritidis isolates. These
genes encode alcohol dehydrogenase, aldehyde dehydro-
genase and enzymes required for ethanolamine utiliza-
tion (eutG, J, E, N, M, D). S. Enteritidis 32/00 also lacks
the pduS gene, a ferredoxin involved in propanediol utili-
zation (part of the pdu operon). In Salmonella both 1, 2-
propanediol degradation and ethanolamine degradation
require vitamin B12. Many Enterobacteriaceae have lost the
capacity to synthesize cobalamine and therefore to
degrade 1, 2-propanediol and ethanolamine but a few
genera, including Salmonella and Yersinia, re-acquired a 40
kb metabolic island encoding both the ability to synthe-
sise cobalamine and degrade 1, 2-propanediol, whilst
retaining the eut operon [36-39]. Although 1, 2-propane-
diol is an important source of energy for S. Typhimurium
and cbi mutants are significantly attenuated in their ability
to grow in macrophages [40] it is apparent that genes
within these pathways are lost in the host-adapted S.
enterica serovars including Gallinarum, Typhi and Para-
typhi A [27].
Region 8 (SEN2761-SEN2763) comprises three genes
(rpoS and two unknown genes) which are absent/diver-
gent in S. Enteritidis 47/03 isolated from human disease.
RpoS is inducible in stationary phase, is the master regu-
lator of the general stress response in Salmonella and is
required for virulence in mice [41,42]. There are previous
reports of S. Typhi, S. Typhimurium and S. Enteritidis
clinical and environmental isolates carrying mutations in
rpoS that result in impaired RpoS functionality [42,43]. A
test of catalase activity in stationary phase is used as a
method to detect RpoS function [42], thus we performed
the test in all 29 isolates and found a negative result only
in S. Enteritidis isolate 47/03. This strongly suggest that
RpoS function is impaired in this isolate.
Region 6 harbouring genes encoding nitrate reductases,
cytochrome C and ferredoxin-type proteins (napC, B, H,
G, A, D), was also absent in 3 S. Enteritidis (31/88, 48/98
and 92/05) isolates from different periods of the Uru-
guayan epidemic.
Variation in S. Enteritidis Genomic Islands
Although there is a large number of genomic islands in S.
Enteritidis PT4 P125109 [27] which carry the hallmarks of
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having been laterally acquired, and maintain mobility
functions, surprisingly our data show that most are ubiq-
uitous in the S. Enteritidis isolates tested here. The excep-
tions are Region 5 (or ROD21) and Region 9. Region 5 is
one of the largest genomic islands identified in S. Enteri-
tidis PT4 P125109 (26.5 kb; SEN1970-SEN1999), and it
encodes the global transcriptional silencers H-NS (hnsB)
and the H-NS antagonist (hnsT) [44-46]. This region was
undetected using the microarray in the Kenyan S. Enteri-
tidis isolate AF3353 but it is present in all other strains.
Region 9 corresponds to the immigration control region
ICR in S. Enteritidis PT4 P125109 [27] which encodes two
type I restriction/modification systems. All of these genes
were not detected in the Kenyan S. Enteritidis isolate
AF3176 and partially detected in isolate 47/03, which
lacks one of the restriction enzyme subunits.
In addition to variation in genes found in large clusters in
S. Enteritidis PT4 P125109 there was also variation in
genes found as singletons (summarised in Tables 3 and
4). Of note is the absence of the gene ratB in S. Enteritidis
isolate 32/00. This gene is located within the CS54
genomic island in S. Typhimurium, a region that is impor-
tant for intestinal persistence in a mouse model [47]. In S.
Enteritidis PT4 P125109, the genomic island is main-
tained but ratB is a pseudogene, as it is in the sequenced
strains of the host-adapted serovars S. Typhi and S. Galli-
narum.
Variation in plasmid-encoded genes
Besides chromosomal genes, the microarray incorporated
genes found on Salmonella virulence plasmids from serov-
ars Enteritidis, Gallinarum, Typhimurium and plasmids,
pHCM1 and pHCM2, from the multi-drug resistant S.
Typhi strain CT18. Five Uruguayan isolates, 2 from food
(206/99 and 32/02) and 3 from human disease (130/99,
199/02 and 214/02), lack the characteristic S. Enteritidis
virulence plasmid. This was confirmed by attempts to
purify the plasmid (Table 2). Two other Uruguayan iso-
lates, 92/05 and 132/99, exhibited divergence in more
than 30 genes and isolates 57/94 and 49/98 diverged in
15 genes found within the plasmid of S. Enteritidis PT4
P125109 (see Table 2 and Figure 2). Included in the genes
predicted as absent or divergent are the spv genes, the pef
fimbrial operon as well as repA (DNA replication) and
rsdB (resolvase). Of note, isolates 92/05 and 132/99 also
lack the few tra genes remaining in S. Enteritidis PT4
P125109.
Despite the high degree of variability seen in these plas-
mids all had similar molecular weights when compared to
that in S. Enteritidis PT4 P125109 (data not shown), sug-
gesting potential divergence in gene sequence or acquisi-
tion of novel genes. However none of the isolates with
high variation in plasmid gene content showed a positive
signal for non-S. Enteritidis plasmid features included in
the array, suggesting that they may harbour sequence
divergence or novel sequences. In fact the only isolate
showing a positive signal for non-S. Enteritidis plasmid
Graphical representation of the 57 genes from the Salmonella virulence plasmid as found in isolates that showed differences in plasmid content by CGHFigure 2
Graphical representation of the 57 genes from the Salmonella virulence plasmid as found in isolates that 
showed differences in plasmid content by CGH. In blue, genes present in the S. Enteritidis PT4 P125109 virulence plas-
mid and predicted as absent in the test strain. In white, genes present in both reference and test strains.
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features was the Kenyan S. Enteritidis isolate AF3353
which harbours the complete S. Enteritidis PT4 P125109
virulence plasmid and shows a positive signal for 10 genes
from the multidrug resistance plasmid, pHCM1, from S.
Typhi CT18. These include genes encoding β-lactamase
and streptomycin resistance. Although we cannot confirm
that these are located on the plasmid there are increasing
numbers of reports of drug resistance genes integrating
into the virulence plasmid [48,49].
Conclusion
The results presented here corroborate and extend previ-
ous reports demonstrating a high degree of genetic homo-
geneity among field isolates of S. Enteritidis, irrespective
of geographical, temporal and source differences. Most of
the strains analysed produced highly similar profiles by
RAPD and PFGE analysis, and those selected for further
analysis showed almost indistinguishable gene content by
microarray-based CGH. The two oldest Uruguayan pre-
epidemic S. Enteritidis isolates and a Kenyan isolate
(AF3353) were among the most divergent. Most of the
genome variation was related to prophage regions under-
scoring their importance as drivers for S. Enteritidis evolu-
tion. In particular half of the isolates from before the
beginning of the S. Enteritidis epidemic in Uruguay lack
ϕSE20, whereas absence of this phage is minimal (less
than 5%) among S. Enteritidis isolated during and after
the epidemics, as detected by CGH and extended by PCR
screening. These results, together with those previously
reported [21] strongly suggest that this phage may have
been relatively recently acquired by S. Enteritidis, and that
this might be related to the capacity of PT4-like strains to
become prevalent. Although we are aware that the small
number of pre-epidemic isolates is a limitation of this
study, it is noteworthy that these are all the S. Enteritidis
isolates received at the National Salmonella Centre since
the beginning of the 1970s until the end of 1994.
The two oldest pre-epidemic isolates also carry genetic
regions that were not found in S. Enteritidis strains previ-
ously evaluated by CGH [21,24,25], but this may be due
to the fact that more genes from other serovars of Salmo-
nella are present on our microarray compared with those
previously reported. Beside these, we have confirmed that
2 Uruguayan isolates harbour gogB, a gene that has not
been previously found among S. Enteritidis strains.
In addition to identifying differences in the content of
mobile genetic elements we were successful in identifying
metabolic pathways which appear to be incomplete in
some isolates. These include those associated with the uti-
lization of propanediol and ethanolamine as well as
many genes that have previously been implicated in bac-
terial fitness and virulence (e.g. global transcriptional
silencers H-NS, immigration control region ICR, rpoS,
gogB, ratB). We also showed that a significant number of
the Uruguayan S. Enteritidis strains lack the Salmonella vir-
ulence plasmid and others showed variation in plasmid
gene content.
There was great heterogeneity in the ability of the isolates
to invade Caco-2 human epithelial cells, but our genotyp-
ing approach was insufficient to elucidate the genetic
bases for these differences. These finding are in agreement
with previous reports that showed that genetically closely
related S. Enteritidis strains nevertheless presented impor-
tant metabolic differences, and that these differences were
related to the accumulation of single nucleotide polymor-
phism rather than with differences in gene content [24].
Of note, none of the genes predicted as variant among S.
Enteritidis in our work correspond to those described as
involved in the ability to survive in the avian reproductive
tract [50] or in persistence in egg albumen [51]. Further-
more, the genetic regions related to metabolic functions
found as variable in our CGH analysis do not correspond
to utilization of the compounds described by Morales et
al. in their comparative phenotypic analysis of S. Enteri-
tidis strains [24].
A report has recently been published showing differences
in genetic content among S. Enteritidis isolates from prev-
alent phage types and the non-prevalent phage type 11
[26]. With the exception of the plasmid-encoded genes,
all other genes reported as exclusively present in the prev-
alent phage types, are also present in all the isolates ana-
lyzed here.
Overall, our study shows that the epidemic of S. Enteri-
tidis in Uruguay between 1995 and 2004 was caused by
highly related S. Enteritidis isolates, perhaps comprising a
PT4-like clonal population with few whole gene differ-
ences. To understand more clearly the link between geno-
type and phenotype and to differentiate between neutral
variation within a population and variations associated
directly with defined phenotypes, the whole genome
sequences of a large number of isolates are required for
association studies. This is our future direction.
Methods
Bacterial isolates
A sample set of 266 isolates of S. Enteritidis isolated in
Uruguay was defined among strains received at the
National Salmonella Centre (Instituto de Higiene, Univer-
sidad de la República, Uruguay). Most (218) were isolated
during the 9 years from 1995 to 2003 during which there
was a nationwide epidemic of food poisoning caused by
S. Enteritidis. These included a selection of 112 isolates
from human cases of gastroenteritis (around 15% of all
isolates from faecal culture during the epidemic), all
recorded isolates from human systemic infection (48
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strains) and all isolates from non-human origin (58
strains). The sample set was completed with all isolates
available (6 strains) from prior to the beginning of the
epidemic, and 42 isolated after the epidemic declined.
The description and source of all Uruguayan strains
included in this study are shown in Tables 1 and 2.
A UK isolate that had been completely sequenced and
annotated (S. Enteritidis PT4 P12519, NCTC 13349) was
used as the reference in all analyses [27]. S. Enteritidis PT4
P125109 is a human food-poisoning isolate which is
highly virulent in newly-hatched chickens.
Six S. Enteritidis isolates from other countries were
included in CGH analysis. Four clinical isolates (AF3172,
AF3173, AF3176, AF3353) were obtained from Centre for
Microbiology Research, Kenya Medical Reserch Institute,
Nairobi, Kenya. Two veterinary isolates (S1400/94 [52]
and 9296/98) were obtained from Veterinary Laboratory
Agency, UK. AF3172, AF3173, S1400/94 belong to phage-
type 4, AF3176 to phage-type 21, 9296/98 to phage-type
1-c and AF3353 has not been phage-typed.
Isolates were maintained frozen at -80°C in LB containing
25% glycerol. Cultures were performed in LB broth, or on
LB containing 1.6% agar, or Tryptic Soy Agar.
All isolates were identified as Salmonella enterica using
standard biochemical microbiological methods. Serovar
was determined by slide agglutination test for O antigens
and tube agglutination test for H antigens using commer-
cially available anti O and anti H serum (Difco, France).
Phage typing of the Uruguayan strains was kindly per-
formed by Muna Anjum and collaborators from the
Department of Food and Environmental Safety, Veteri-
nary Laboratories Agency, Addlestone, UK.
Genotyping analysis
All 266 S. Enteritidis were subjected to random amplified
polymorphism DNA-PCR (RAPD-PCR) analysis using 5
different primers and S. Enteritidis PT4 P125109 [27] as
reference. A selection of 37 isolates was further subjected
to pulse field gel electrophoresis (PFGE) after XbaI restric-
tion.
RAPD-PCR was performed as previously described [12].
PFGE of total DNA was performed at the Instituto Carlos
Malbran, Buenos Aires, Argentina, following the protocol
recommended by PulseNet http://www.cdc.gov/pulsenet/
protocols.htm and using a CHEF-DRIII SYS220/240 (Bio-
Rad). The electrophoresis profile of each strain was com-
pared to that of PT4 P125109 using Bionumerics software
(Applied Maths, St. Martens-Latern, Belgium) and similar-
ity compared using Dice's coefficient. Results are
expressed as percentage of identity related to PT4
P125109: 96% of identity corresponds to 1 band of differ-
ence, 92% to 2 bands and 91% to 3 bands of difference.
Plasmid DNA was extracted and analyzed by a procedure
modified from the method of Kado and Liu [53]. Briefly,
1.5 ml of an LB overnight culture were harvested by cen-
trifugation and suspended in 200 μl E buffer (40 mM Tris,
1 mM EDTA, pH 8,0), mixed gently with 400 μl of lysis
solution (50 mM Tris, 100 mM SDS, pH 12,6) and incu-
bated at 58°C for 60 min. 600 μl of phenol/chloroform/
isoamyl alcohol (25: 24: 1) solution was mixed gently and
the aqueous phase was subjected to phenol/chloroform
extraction followed by centrifugation.
Caco-2 invasion assays
The human colon carcinoma (Caco-2) cell line was
obtained from the American Type Culture Collection
(ATCC). Caco-2 cells were maintained in DMEM (high
glucose, 4500 mg/l), supplemented with 4 mM L-
glutamine and 10% foetal calf serum at 37°C in an atmos-
phere including 5% CO2, up to 80% confluence.
For invasion assays, cells were seeded on 24-well plates at
a density of 5 × 104 cells per well, and grown for three days
(changing media every other day). The day before the
assay, a single colony of each bacterial strain was inocu-
lated in 3 ml of LB broth and grown overnight in an
orbital shaking incubator at 37°C (200 rpm). The follow-
ing day, bacterial cultures were diluted 1/100 in fresh LB
and grown with shaking for approximately 2 h to an
OD600 of 0.4-0.6. Appropriate volumes of bacterial cul-
tures (to give a multiplicity of infection of about 30 bacte-
ria/cell) were spun for 2 minutes at 5500 g, then bacteria
were re-suspended by pipetting in Caco-2 growth media
and 0.5 ml of this were used to overlay the Caco-2 mon-
olayer. After 1 hour of incubation to allow invasion, the
monolayer was washed twice with 1 ml of pre-warmed
Dulbecco's PBS (Sigma) and extracellular bacteria were
killed by adding medium containing 100 ug/ml of gen-
tamicin (Sigma). After incubation for 90 min, 20 ul of cul-
ture supernatants were plated in triplicate in LB agar plates
to verify that no viable bacteria were remaining. Cells were
washed three times in PBS and then lysed with 0.5 ml of
0.1% Triton X-100 (in water), by incubating for 20 min at
37°C and vigorously pipetting to release intracellular bac-
teria. Serial 10-fold dilutions of lysates, as well as the cor-
responding inocula, were plated on LB agar plates for
counting viable colonies. For each isolate the percentage
of bacteria recovered from intracellular environment to
the original inocula was calculated, and this value was
normalized so that the invasiveness of the reference strain
S. Enteritidis PT4 P125109 was 100%. Each strain was
tested in duplicate or triplicate, in at least two separate
experiments. The mean of all experiments and replicates
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for each strain was used to assign an invasiveness level
expressed as - (≤ 30% of the reference) or + (> 30%). Sus-
ceptibility of the isolates to gentamicin was verified using
Kirby-Bauer disk diffusion method (NCCLS 2005), and
all isolates were susceptible. For statistical analysis to
compare the invasiveness of isolates, we used one way
ANOVA and Dunnett's multiple comparison test using an
alpha = 0,01 (GraphPad Prism software). Fisher's exact
test was used to compare the behaviour of isolates
obtained from gastroenteritis and invasive disease.
Comparative Genomic Hybridization analysis
Twenty nine Uruguayan, 4 S. Enteritidis isolates from
Kenya and 2 from the UK (see Table 2), were analysed by
CGH using either the Salmonella generation III or IV
microarray and S. Enteritidis PT4 P125109 as reference
[27]. Both Salmonella Microarray Generation III and IV
http://www.sanger.ac.uk/Projects/Salmonella/ are an
extension of the previously described Salmonella Genera-
tion I Microarray constructed at the Wellcome Trust
Sanger Institute [20,22]. These are non-redundant arrays
containing coding sequences from the following
genomes: S. Typhi CT18, S. Typhi Ty2, S. Typhimurium
LT2 (ATCC 700220), S. Typhimurium DT104 (NCTC
13348), S. Typhimurium SL1344 (NCTC 13347), S.
Enteritidis PT4 (NCTC 13349), S. Gallinarum 287/91
(NCTC 13346) and S. bongori 12419 (ATCC 43975). The
arrays differed on spot layout and positive controls, which
were however, not taken into account for analysis pur-
poses.
Total DNA from each strain (including plasmid DNA) was
extracted using a Genome DNA extraction kit (Promega)
and quantified by agarose gel electrophoresis. Each DNA
sample was diluted to 0.1 μg/ml, sonicated for 10 seconds
(level 2; Virsonic 300 sonicator) and then labelled with
Cy5 (test) or Cy3 (control) using the Bioprime kit (Gibco-
BRL) as per manufacturer's instructions. Labeled DNA
from S. Enteritidis PT4 P125109 (control sample) and
one of the query Salmonella isolates (experimental sam-
ple) were mixed in equal volumes and concentrations.
Dye-swap labelling experiments were also performed for
each test sample. Mixed labelled DNA was cleaned using
an Autoseq G-50 column (Amersham), denatured, and
precipitated, and the resulting probes were hybridized to
the microarray slide for 17 h at 49°C in a hybridization
chamber (Genetix X2530). Washing procedures were
stringent with 2 washes at 65°C in 2 × SSC, 0.1% SDS for
30 min and 2 washes at 65°C in 0.1 × SSC for 30 min (1
× SSC is 0.15 M NaCl plus 0.015 M sodium citrate).
Hybridization to microarray slides was detected using a
Genepix 4000B scanner (Axon Instruments, Inc.) and
quantified using Genepix Pro software (Axon Instru-
ments, Inc.). Signal intensities were corrected by subtract-
ing local background values. Normalization was
performed across all features on the array before any filter-
ing took place. Data were normalized to the median value
and the total list of 6871 genes was filtered by removing
those spots with a high background and genes without
data in at least one of the replicates (3 slides per strain,
duplicate features per slide). After filtering, a list of 5863
genes was obtained that corresponded to genes that pre-
sented a valid signal in at least one of the strains analyzed.
Normalization and filtering were performed using Gene-
Spring microarray analysis software V7.2 (Silicon Genet-
ics). Data analysis was performed on Excel files, following
criteria previously described [21] with some modifica-
tions, as described below.
Calling of genes present in the PT4 P125109 genome
(3978 genes): spots showing low signal when hybridized
with PT4 P125109 DNA (median contribution of the ref-
erence signal replicates to the total signal among the low-
est 5% of all PT4 genes) were assigned as "uncertain". For
all other genes, the median of the query strain/PT4 ratios
was registered and values higher than 0.67 were assigned
as "present" in the query strain whereas those with a ratio
value lower than 0.33 were assigned as "absent/divergent"
in the query strain. Intermediate ratio values were regis-
tered as "uncertain".
Calling of genes absent in the PT4 P125109 genome
(1885 genes): if the median contribution of all spots per
gene was among the top 70% of all genes represented on
the array and the ratio of query strain/PT4 signals was
higher than 2.5 the gene was defined as "present" in the
query strain. If the median contribution was among the
bottom 20% of all genes in the array, the gene was called
"absent". Spots that fell outside of these categories were
called "uncertain".
For validation, we applied this method to predict genes as
being present or absent in the S. Typhi CT18 and S. Typh-
imurium DT104 sequenced strains and found an error of
less than 1% for prediction of absent/divergent genes, and
an error less than 0,1% for prediction of present genes.
These mean that from one hundred of genes predicted as
absent/divergent in test strain, one can be wrongly
included in this category and that from one thousand of
genes predicted as present in test strain, one can be
wrongly assigned to this category.
Raw microarray data and grid files were submitted to
ArrayExpress with accession number E-TABM-603
http:www.ebi.ac.uk/microarray-as/ae/browse.html?key
words=E-TABM-603
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Validation of CGH data by PCR
All PCR reactions were performed using colony-extracted
total DNA as template and invA as positive control in a
multiplex PCR. Primers used to test the presence of ϕSE20
were previously described by Morales et al [24]. Primers
used to amplify gogB were: gogB-F 5'CTGCAATCTGCCT-
GCACATATAG-3' and gogB-R 5'CCCAGACCGCATCTGT-
TAATG-3'. invA primers (inv139 and inv141) were
previously described by Malorny et al [54]. PCRs were per-
formed in 25 μl reactions with a final concentration of 2
mM MgCl2, 200 μM each dNTP, 0.0375 U/μl of Taq DNA
polymerase (Fermentas), in a Corbett Palm-Cycler. Prim-
ers concentrations were: 0.15 μM for sb9, sb41 or gogB and
0.5 μM for invA. The cycling program was as follows: 5
min at 95°C followed by 30 cycles of 30 s at 94°C, 30 s at
60°C and 30 s at 72°C, and completed by a final exten-
sion for 5 min at 72°C. Presence and sizes of PCR ampli-
cons were verified by electrophoresis on 2.5% agarose gels
in 0.5× TBE.
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